Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Duloxetine Delayed-release NDC 71610-218 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 30 mg - 71610 0218 30
Aphena Pharma Solutions - TN - Aphena
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
This is a graph that shows the proportion of patients who experienced relapse over time from randomization to relapse, in days, for two different treatments (placebo and duloxetine). The data is presented in percentages ranging from 0 to 10.*
Figure 2 - duloxetine 03
This is a graph showing the proportion of patients experiencing relapse over time from randomization to relapse (in days) for a treatment group receiving Duloxetine compared to a group receiving a placebo. The x-axis represents the number of days, and the y-axis represents the proportion of patients affected. The data is shown through five bars, with the highest proportion of relapse at day 10 for both groups, and the lowest proportion at day 250.*
Figure 3 - duloxetine 04
The text is describing a chart displaying the percentage of patients and their improvement in pain from baseline. The x-axis shows the percent improvement in pain from baseline while the y-axis displays the percent of patients improved. The chart shows that no patients were improved by 0%, 210 patients by 22%, 230 patients by 24%, and so on. The text also mentions some medication options, but it is not clear how they relate to the chart.*
Figure 4 - duloxetine 05
Figure 7 - duloxetine 06
This is a chart or graph showing the percentage of patients who experienced improvement in pain after being treated with a drug, compared to those who received a placebo. The drug being evaluated is likely named DUL, and was administered at a dose of 601120 mg once daily. The x-axis shows the degree of improvement in pain, ranging from 0% to 100%, while the y-axis displays the percentage of patients who experienced that level of improvement.*
Figure 8 - duloxetine 07
Figure 9 - duloxetine 08
The graph shows the percentage of patients improved in terms of pain from baseline using a placebo and DUL at 60/120 mg once daily. The x-axis represents the percent improvement in pain from baseline, while the y-axis represents the percentage of patients improved.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.